GNRH1 and hyperprolactinemia: In the context of hyperprolactinemia, changes in BMD levels can be triggered either indirectly, through the suppression of the GnRH–gonadal axis caused by elevated prolactin levels, or directly, via prolactin’s influence on osteoblasts and potentially osteoclast cells.